(Q43885735)

27 November 2017

title

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease (English)

1 reference

27 November 2017

0 references

0 references

1

1 reference

27 November 2017

Arai H

2

1 reference

27 November 2017

Maruyama M

3

1 reference

27 November 2017

Matsui T

4

1 reference

27 November 2017

Tanji H

5

1 reference

27 November 2017

Sasaki H

6

1 reference

27 November 2017

Yoshida H

7

1 reference

27 November 2017

Sugita M

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Journal of the American Geriatrics Society

27 November 2017

published in

1 reference

27 November 2017

volume

49

1 reference

27 November 2017

issue

12

1 reference

27 November 2017

page(s)

1738-1739

1 reference

Statins and the risk of dementia

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49293.X

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49293.X

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49293.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49293.X

Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49293.X

10.1046/J.1532-5415.2001.49293.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference